Skip to main content
Premium Trial:

Request an Annual Quote

HTG Molecular Diagnostics to Implement Reverse Stock Split

NEW YORK — HTG Molecular Diagnostics on Monday filed a document with the US Securities and Exchange Commission to effect a 1-for-12 reverse stock split of its outstanding common stock.

The move, which was authorized by the company's stockholders last month, will take effect at the opening of the market on Dec. 21, HTG Molecular said in the filing. It follows a 1-for-15 reverse stock split the company completed in late 2020.

During Tuesday morning trading on the Nasdaq, shares of HTG Molecular were down around 7 percent at $.7664.

About a month ago, the Tucson, Arizona-based company posted a 48 percent year-over-year drop in third quarter revenues as it repositions itself as a drug discovery technology developer.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.